Side Effects

When Do Ozempic Side Effects Start? A Week-by-Week Timeline

GLP-1 Companion · 9 min read

Quick answer

Most Ozempic side effects begin within 24 to 48 hours of the first injection, peak during dose escalation, and typically improve as your body adapts. Here is an honest week-by-week breakdown of the semaglutide side effect timeline.

One of the most common questions from people starting Ozempic (semaglutide) is: "When will the side effects kick in?" The short answer is that most side effects — particularly gastrointestinal ones like nausea — can begin within hours of your first injection. But the full picture is more nuanced, because the timing, intensity, and duration of side effects vary considerably based on where you are in the dose escalation schedule.

This article walks through what clinical data and patient experience tell us about when Ozempic side effects typically start, how long they last, and what tends to happen at each stage of treatment.

The First 24–48 Hours After Injection

Ozempic is a once-weekly injection. Most people notice the earliest effects within the first 24 hours — sometimes sooner. Common initial experiences include:

  • Mild nausea (often described as a vague queasiness rather than acute sickness)
  • Reduced appetite — sometimes dramatically so within the first day
  • Mild fatigue or feeling slightly "off"
  • Injection site reactions: redness, itching, or a small lump at the injection site (usually temporary)
  • Mild indigestion or stomach discomfort

At the starting dose of 0.25 mg, these effects are usually mild for most patients. The reduced appetite effect, however, can feel quite pronounced — many people report simply not feeling hungry at all for the first several days. This is the GLP-1 receptor agonist working as intended: slowing gastric emptying and signaling satiety to the brain.

Week 1–4: The Starting Dose (0.25 mg)

The standard Ozempic starting dose is 0.25 mg weekly for the first four weeks. This is considered a titration dose — below the therapeutic weight-management dose — specifically to minimize side effects while your body adjusts. During this phase:

  • Nausea is present but usually manageable; most people rate it mild to moderate
  • Constipation can begin in week 1 as gastrointestinal motility slows
  • Some people experience diarrhea instead — GI responses vary significantly between individuals
  • Appetite suppression is often noticeable even at this low dose
  • Headaches occur in some users, often linked to reduced calorie and fluid intake
  • Fatigue is common and often tied to eating significantly less than usual

Week 5–8: First Dose Increase (0.5 mg)

After four weeks at 0.25 mg, the standard protocol increases the dose to 0.5 mg weekly. For many people, this is when side effects become more noticeable. Clinical trial data shows that GI side effects peak during dose escalation periods. What to expect:

  • Nausea often intensifies for 1–2 weeks after the dose increase before subsiding again
  • Vomiting becomes more common at this dose (reported by roughly 5–9% of users)
  • Constipation may worsen; in some patients it becomes a persistent issue requiring dietary adjustment
  • Burping and acid reflux become more common as gastric emptying slows further
  • Dizziness can occur, especially if you are eating less and staying less hydrated
  • The "food noise" reduction — the quieting of constant food thoughts — is typically very noticeable by this stage

A useful rule of thumb: any time your dose increases, expect 1–2 weeks of elevated side effects as your body recalibrates. After that window, symptoms typically improve significantly before the next dose increase.

Week 9–16: Moving to 1 mg

If you are using Ozempic for weight management (or your doctor adjusts your dose upward), the next step is typically 1 mg weekly. This is the primary approved dose for type 2 diabetes management. At 1 mg:

  • GI side effects generally follow the same pattern: temporary increase at dose change, then gradual improvement
  • Most people find side effects at 1 mg are comparable in intensity to 0.5 mg after the initial adjustment
  • Hair thinning (telogen effluvium) sometimes becomes noticeable around this period — it is related to rapid weight loss, not the medication directly, and usually resolves
  • Sleep changes — vivid dreams or sleeping better/worse — are occasionally reported
  • Energy levels often stabilize as the body adapts to the new dietary intake

Week 17 Onwards: Maintenance or Higher Doses (2 mg)

For patients prescribed the 2 mg dose (the highest approved Ozempic dose, typically used for additional glycemic control in type 2 diabetes), the same escalation pattern applies. Some patients are surprised that 2 mg does not necessarily produce dramatically more side effects than 1 mg — the body's adaptation to the medication mechanism means GI symptoms are often better tolerated at month 4 than they were at month 1, even at higher doses.

By month 3–4, most patients who have remained on Ozempic report that side effects have substantially improved. Nausea, in particular, tends to be much more manageable at the maintenance phase than it was during active dose escalation.

Side Effects That Can Appear at Any Time

Some side effects are not dose-dependent or time-limited — they can appear at any point during treatment:

  • Gastroparesis symptoms (severe delayed gastric emptying): bloating, feeling full after tiny amounts, regurgitation — less common but can develop in long-term users
  • Gallbladder issues: rapid weight loss increases gallstone risk; symptoms include right upper abdominal pain after eating
  • Pancreatitis (rare but serious): sudden severe abdominal pain radiating to the back — stop medication and seek medical attention immediately
  • Thyroid concerns: in rodent studies, GLP-1 agonists increased thyroid tumor risk; clinical significance in humans is still being studied; discuss if you have a personal or family history of thyroid cancer
  • Injection site reactions: can develop even after weeks or months of injections without any issue

How Long Do Ozempic Side Effects Last?

Across clinical trials for Ozempic and its weight-loss cousin Wegovy (also semaglutide), the consensus is that:

  • Nausea typically peaks in the first 4 weeks of each dose level and improves substantially by weeks 6–8
  • Constipation and diarrhea can persist longer but are usually manageable with dietary adjustments
  • Injection site reactions are almost always temporary (days, not weeks)
  • Fatigue often improves as the body adjusts to a new caloric baseline
  • Side effects that persist beyond 2–3 months at a stable dose — especially GI symptoms — are worth discussing with your doctor, as they may indicate a dose reduction is appropriate

Tips to Minimize Side Effects at Each Stage

  • Inject on the same day each week, ideally at the same time
  • Eat smaller, more frequent meals — large meals significantly worsen nausea
  • Avoid high-fat and high-sugar foods, particularly in the first few weeks
  • Stay well-hydrated: sip water throughout the day
  • Give the medication time: most patients who push through the first 4–8 weeks report that side effects improve substantially
  • Talk to your doctor about anti-nausea medications (such as ondansetron) if nausea is severely impacting quality of life
  • Do not self-discontinue — stopping and restarting can reset the adaptation process and bring side effects back from the beginning

Summary: Ozempic Side Effect Timeline

Here is a condensed overview of when to expect side effects at each phase of Ozempic treatment:

  • Hours 1–24 after first injection: mild nausea, appetite suppression, possible injection site reaction
  • Weeks 1–4 (0.25 mg): mild to moderate nausea, constipation, fatigue, appetite suppression — usually manageable
  • Weeks 5–8 (dose increase to 0.5 mg): temporary spike in nausea, possible vomiting, increased acid reflux
  • Weeks 9–16 (1 mg): another adjustment period, then stabilization; hair thinning may appear (from weight loss)
  • Months 3–4 onwards: side effects typically improve significantly; nausea is usually mild or absent
  • Ongoing: gallbladder vigilance, continued monitoring for rare but serious events

Sources

Related GLP-1 guides